21.06.2024 01:20 - About Us - Mediadaten - Imprint & Contact - succidia AG
Scientist > Prof. Dr Jan F.C. Glatz

Prof. Dr Jan F.C. Glatz

//born 1955, studied chemistry and biochemistry in Nijmegen and Utrecht, acquiring a doctorate in 1983

// After a post-doctorate stay at the University of Wageningen he moved to the University of Maastricht in 1986, where he worked in the field of molecular medicine in conjunction with the lipid metabolism of the heart, in particular with the function and significance of fatty-acid-binding proteins

// During this period he made the lucky discovery that the cyto­plasmatic protein FABP is a biomarker for myocardial infarction. Glatz is Professor of Cardiac Metabolism at the Cardiovascular Research ­Institute of Maastricht (CARIM), University of Maastricht, Netherlands

// His present research work is focuses on membrane substrate transporters and diseases of the cardiac metabolism.

Contact: laborundmore@succidia.de

The earliest plasma marker for myocardial infarction

Fabulous FABP - von Prof Dr Reinhard Renneberg, Prof. Dr Jan F.C. Glatz

The application of Fatty Acid-Binding Protein (FABP) as a plasma marker for the diagnosis of acute myo­cardial infarction was first suggested in 1988. Currently, FABP is proven to have added value for the diagnosis­ of patients presenting with chest pain suggestive of myocardial infarction, especially in the early hours after onset of symptoms. The routine application of FABP for this purpose not only will improve patient outcome but also markedly...